This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Oh MY, Oh SB, Seoung HG, Kim JH, Kim SM, Kim TK, et al. Clinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large B cell lymphoma. Korean J Hemato 2012; 47: 207-12.OhMYOhSBSeoungHGKimJHKimSMKimTKClinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large B cell lymphomaKorean J Hemato2012472071210.5045/kjh.2012.47.3.207Search in Google Scholar
Kashyap R, Rai Mittal B, Manohar K, Balasubramanian Harisankar CN, Bhattacharya A, Singh B, et al. Extranodal manifestations of lymphoma on [18F]FDG-PET/CT: a pictorial essay. Cancer Imaging 2011; 11: 166-74.KashyapRMittalB RaiManoharKHarisankarCN BalasubramanianBhattacharyaASinghBExtranodal manifestations of lymphoma on [18F]FDG-PET/CT: a pictorial essayCancer Imaging2011111667410.1102/1470-7330.2011.0023Search in Google Scholar
Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin’s lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8: 727-37.ZuccaERoggeroEBertoniFCavalliFPrimary extranodal non-Hodgkin’s lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomasAnn Oncol199787273710.1023/A:1008282818705Search in Google Scholar
Glass AG, Karnell LH, Menck HR. The National Cancer Data Base report on non-Hodgkin’s lymphoma. Cancer 1997; 80: 2311-20.GlassAGKarnellLHMenckHRThe National Cancer Data Base report on non-Hodgkin’s lymphomaCancer19978023112010.1002/(SICI)1097-0142(19971215)80:12<2311::AID-CNCR13>3.0.CO;2-XSearch in Google Scholar
Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29: 252-60.FreemanCBergJWCutlerSJOccurrence and prognosis of extranodal lymphomasCancer1972292526010.1002/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#Search in Google Scholar
d’Amore F, Christensen BE, Brincker H, Pedersen NT, Thorling K, Hastrup J, et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer 1991; 27: 1201-8.d’AmoreFChristensenBEBrinckerHPedersenNTThorlingKHastrupJClinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study GroupEur J Cancer1991271201810.1016/0277-5379(91)90081-NSearch in Google Scholar
Schrepfer T, Haerle SK, Strobel K, Schaefer N, Hälg RA, Huber GF. The value of (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas. Laryngoscope 2010; 120: 937-44.SchrepferTHaerleSKStrobelKSchaeferNHälgRAHuberGFThe value of (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomasLaryngoscope201012093744Search in Google Scholar
Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, andresponse assessment of Hodgkin and Non-Hodgkin lymphoma: the Luganoclassification. J Clin Oncol 2014; 32: 3059-67.ChesonBDFisherRIBarringtonSFCavalliFSchwartzLHZuccaERecommendations for initial evaluation, staging, andresponse assessment of Hodgkin and Non-Hodgkin lymphoma: the LuganoclassificationJ Clin Oncol20143230596710.1200/JCO.2013.54.8800Search in Google Scholar
Ezzat AA, Ibrahim EM, El Weshi AN, Khafaga YM, AlJurf M, Martin JM, et al. Localized non-Hodgkin’s lymphoma of Waldeyer’s ring: clinical features, management, and prognosis of 130 adult patients. Head Neck 2001; 23: 547-58.EzzatAAIbrahimEMWeshiAN ElKhafagaYMAlJurfMMartinJMLocalized non-Hodgkin’s lymphoma of Waldeyer’s ring: clinical features, management, and prognosis of 130 adult patientsHead Neck2001235475810.1002/hed.1077Search in Google Scholar
Dodd GD. Lymphoma of the hollow abdominal viscera. Radiol Clin North Am 1990; 28: 771-83.DoddGDLymphoma of the hollow abdominal visceraRadiol Clin North Am1990287718310.1016/S0033-8389(22)01260-XSearch in Google Scholar
Gollub MJ. Imaging of gastrointestinal lymphoma. Radiol Clin North Am 2008; 46: 287-312.GollubMJImaging of gastrointestinal lymphomaRadiol Clin North Am20084628731210.1016/j.rcl.2008.03.002Search in Google Scholar
Gutjahr P, Humpl T. Testicular lymphoblastic leukemia/lymphoma. World J Urol 1995; 13: 230-2.GutjahrPHumplTTesticular lymphoblastic leukemia/lymphomaWorld J Urol199513230210.1007/BF00182968Search in Google Scholar
Henry JM, Heffner RR Jr, Dillard SH, Earle KM, Davis RL. Primary malignant lymphomas of the central nervous system. Cancer 1974; 34: 1293-302.HenryJMHeffnerRRJrDillardSHEarleKMDavisRLPrimary malignant lymphomas of the central nervous systemCancer197434129330210.1002/1097-0142(197410)34:4<1293::AID-CNCR2820340441>3.0.CO;2-PSearch in Google Scholar
Weiler-Sagie M, Bushelev O, Epelbaum R, Dann EJ, Haim N, Avivi I, et al. (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med 2010; 51: 25-30.Weiler-SagieMBushelevOEpelbaumRDannEJHaimNAviviI(18)F-FDG avidity in lymphoma readdressed: a study of 766 patientsJ Nucl Med201051253010.2967/jnumed.109.067892Search in Google Scholar
Ostrowski ML, Unni KK, Banks PM, Shives TC, Evans RG, O’Connell MJ, et al. Malignant lymphoma of bone. Cancer 1986; 58: 2646-55.OstrowskiMLUnniKKBanksPMShivesTCEvansRGO’ConnellMJMalignant lymphoma of boneCancer19865826465510.1002/1097-0142(19861215)58:12<2646::AID-CNCR2820581217>3.0.CO;2-USearch in Google Scholar
Lee KS, Kim Y, Primack SL. Imaging of pulmonary lymphomas. AJR Am J Roentgenol 1997; 168: 339-45.LeeKSKimYPrimackSLImaging of pulmonary lymphomasAJR Am J Roentgenol19971683394510.2214/ajr.168.2.9016202Search in Google Scholar
Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. Eur Respir J 2002; 20: 750-62.CadranelJWislezMAntoineMPrimary pulmonary lymphomaEur Respir J2002207506210.1183/09031936.02.00404102Search in Google Scholar
Giardini R, Piccolo C, Rilke F. Primary non-Hodgkin’s lymphomas of the female breast. Cancer 1992; 69: 725-35.GiardiniRPiccoloCRilkeFPrimary non-Hodgkin’s lymphomas of the female breastCancer1992697253510.1002/1097-0142(19920201)69:3<725::AID-CNCR2820690320>3.0.CO;2-CSearch in Google Scholar
Jerusalem G, Beguin Y, Najjar F, Hustinx R, Fassotte MF, Rigo P, et al. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin’s lymphoma (NHL). Ann Oncol 2001; 12: 825-30.JerusalemGBeguinYNajjarFHustinxRFassotteMFRigoPPositron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin’s lymphoma (NHL)Ann Oncol2001128253010.1023/A:1011169332265Search in Google Scholar
Alavi A, Shrikanthan S, Aydin A, Talanow R, Schuster S. Fluorodeoxyglucose-positron-emission tomography findings in mantle cell lymphoma. Clin Lymphoma Myeloma Leuk 2011; 11: 261-6.AlaviAShrikanthanSAydinATalanowRSchusterSFluorodeoxyglucose-positron-emission tomography findings in mantle cell lymphomaClin Lymphoma Myeloma Leuk201111261610.1016/j.clml.2011.03.013Search in Google Scholar
Cavalli F, Isaacson PG, Gascoyne RD, Zucca E. MALT Lymphomas. Hematology Am Soc Hematol Educ Program 2001: 241-58.CavalliFIsaacsonPGGascoyneRDZuccaEMALT LymphomasHematology Am Soc Hematol Educ Program20012415810.1182/asheducation-2001.1.241Search in Google Scholar
Beal KP, Yeung HW, Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. Ann Oncol 2005; 16: 473-80.BealKPYeungHWYahalomJFDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 casesAnn Oncol2005164738010.1093/annonc/mdi093Search in Google Scholar
Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107: 265-76.MortonLMWangSSDevesaSSHartgePWeisenburgerDDLinetMSLymphoma incidence patterns by WHO subtype in the United States, 1992-2001Blood20061072657610.1182/blood-2005-06-2508189534816150940Search in Google Scholar
Bailly C, Eugène T, Couec ML, Strullu M, Frampas E, Campion L, et al. Prognostic value and clinical impact of 18FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapy. Front Med (Lausanne) 2014; 1: 54.BaillyCEugèneTCouecMLStrulluMFrampasECampionLPrognostic value and clinical impact of 18FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapyFront Med (Lausanne)201415410.3389/fmed.2014.00054429217325593926Search in Google Scholar
Rizvi MA, Evens AM, Tallman MS, Nelson BP, Rosen ST. T-cell non-Hodgkin lymphoma. Blood 2006; 107: 1255-64.RizviMAEvensAMTallmanMSNelsonBPRosenSTT-cell non-Hodgkin lymphomaBlood200610712556410.1182/blood-2005-03-130616210342Search in Google Scholar
Song MK, Chung JS, Lee JJ, Jeong SY, Lee SM, Hong JS, et al. Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin’s lymphoma. Cancer Sci 2013; 104: 1656-61.SongMKChungJSLeeJJJeongSYLeeSMHongJSMetabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin’s lymphomaCancer Sci201310416566110.1111/cas.12282765352024033666Search in Google Scholar
Kim TM, Paeng JC, Chun IK, Keam B, Jeon YK, Lee SH, et al. Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma. Cancer 2013; 119: 1195-202.KimTMPaengJCChunIKKeamBJeonYKLeeSHTotal lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphomaCancer2013119119520210.1002/cncr.2785523212736Search in Google Scholar
Esfahani SA, Heidari P, Halpern EF, Hochberg EP, Palmer EL, Mahmood U. Baseline total lesion glycolysis measured with (18)F-FDG PET/CT as a predictor of progression-free survival in diffuse large B-cell lymphoma: a pilot study. Am J Nucl Med Mol Imaging 2013; 3: 272-81.EsfahaniSAHeidariPHalpernEFHochbergEPPalmerELMahmoodUBaseline total lesion glycolysis measured with (18)F-FDG PET/CT as a predictor of progression-free survival in diffuse large B-cell lymphoma: a pilot studyAm J Nucl Med Mol Imaging2013327281Search in Google Scholar
Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D, et al. F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma. Eur J Haematol 2014; 92: 382-9.GallicchioRMansuetoGSimeonVNardelliAGuarigliaRCapacchioneDF-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphomaEur J Haematol201492382910.1111/ejh.1226824428392Search in Google Scholar
Ceriani L, Martelli M, Zinzani PL, Ferreri AJ, Botto B, Stelitano C, et al. Utility of baseline 18FDG PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma. Blood 2015; 126: 950-6.CerianiLMartelliMZinzaniPLFerreriAJBottoBStelitanoCUtility of baseline 18FDG PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphomaBlood2015126950610.1182/blood-2014-12-61647426089397Search in Google Scholar
